India Plans Standard Evaluation And Quality Protocols For HMPV' Testing Kits

1/30/2025 3:22:05 PM

(MENAFN- Live Mint) New Delhi: Drug regulator Central Drugs Standard Control Organization (CDSCO) and the Indian Council of Medical Research (ICMR) are firming up standard evaluation and quality protocols for Human Metapneumovirus (HMPV) testing kits following a recent surge in cases.

The union health Ministry on 6 January reported 2 cases of HMPV in Karnataka detected by ICMR during routine surveillance. However, on 9 January, Mint reported that India had witnessed around 200 HMPV cases till December last year.

There is no uniformity in the performance evaluation of such kits at present, which leads to variations in test results. HMPV attracted attention globally after China reported a surge in respiratory illness with flu-like symptoms in December.

Also read | HMPV virus: How doctors are using social media, humour to educate people

“CDSCO and ICMR have aimed at facilitating the availability of quality-assured diagnostics kits appropriate for use in India. The guidelines shall establish the uniformity in performance evaluation of in-vitro diagnostic kits (IVD). The performance evaluation is to independently verify the manufacturer's claim regarding in-vitro diagnostic kit (IVD) performance. This recommendation focuses on the laboratory performance evaluation of Human Metapneumovirus (hMPV) virus real time PCR kit,” said a guidance document seen by Mint.

HMPV is one of many respiratory viruses that can cause infections in people of all ages, especially in the winter and early spring months. The draft guidelines have been issued, with the industry' comment sought by 15 March to finalize the protocol.

“Quality and safety are very important in testing samples. It should be100% accurate and most of the time, manufacturers claim, it is not. Right now, for HMPV, National Institute of Virology (NIV) does the testing along with other central labs. This guideline will bring uniformity and consistency,” said an official aware of the matter.

MENAFN30012025007365015876ID1109150660

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.